DUET BIOTHERAPEUTICS

duet-biotherapeutics-logo

A Scopus BioPharma company creating targeted immunotherapies for treatment-resistant cancers.

#SimilarOrganizations #People #Website #More

DUET BIOTHERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2021-01-01

Address:
Pasadena, California, United States

Country:
United States

Website Url:
http://www.duettx.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

tvax-biomedical-logo

TVAX Biomedical

TVAX Biomedical develops cell-based immunotherapy for the treatment of cancer.

Current Employees Featured

alan-horsager_image

Alan Horsager
Alan Horsager CEO @ Duet BioTherapeutics
CEO
2021-06-01

not_available_image

Marcin Kortylewski
Marcin Kortylewski Co-founder @ Duet BioTherapeutics
Co-founder

nagy-habib_image

Nagy Habib
Nagy Habib Co-Founder @ Duet BioTherapeutics
Co-Founder

not_available_image

John Rossi
John Rossi Co-Founder @ Duet BioTherapeutics
Co-Founder

Founder


not_available_image

John Rossi

not_available_image

Marcin Kortylewski

nagy-habib_image

Nagy Habib

Official Site Inspections

http://www.duettx.com Semrush global rank: 5.89 M Semrush visits lastest month: 1.4 K

Unable to get host informations!!!

Loading ...

More informations about "Duet BioTherapeutics"

Duet BioTherapeutics - Crunchbase Company Profile & Funding

Organization. Duet BioTherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; โ€ฆSee details»

Home - Duet Therapeutics

Creating targeted immunotherapies for treatment-resistant cancers.. Home; About; Approach; Pipeline; News & Resources; Contact; MenuSee details»

Duet BioTherapeutics | LinkedIn

Duet BioTherapeutics is an immunotherapy company creating a new category of bispecific oligonucleotide treatments designed to target dormant immune cells within the tumor โ€ฆSee details»

Duet BioTherapeutics - VentureRadar

Duet BioTherapeutics is a clinical-stage immuno-oncology company creating a new category of bifunctional and cell-selective oligonucleotide... ... Find out more about ...See details»

Duet BioTherapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...

Jul 1, 2023 Explore Duet BioTherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Immune System Diseases, Hemic โ€ฆSee details»

Alan Horsager - President & CEO @ Duet BioTherapeutics

Website www.duettx.com ; LinkedIn View on LinkedIn ; Twitter View on Twitter ; Alan Horsager, Ph.D. is a life science executive developing genetic medicines for human diseases. His career โ€ฆSee details»

Duet BioTherapeutics Overview | SignalHire Company Profile

Duet BioTherapeutics is an immunotherapy company creating a new category of bispecific oligonucleotide treatments designed to target dormant immune cells within the tumor โ€ฆSee details»

Duet BioTherapeutics, Inc. (Duet BioTherapeutics, Inc.) - ่ฏ็‰ฉ็ฎก็บฟ_ โ€ฆ

DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other โ€ฆSee details»

Duet Therapeutics - Overview, News & Similar companies

Www.duettx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Who is Duet Therapeutics. Duet โ€ฆSee details»

SEC.gov | HOME

STAT3 as an I - O target 7 STAT3 is a master regulator of the immune system and a high - value immuno - oncology target, but requires cell - specific modulation Tumor cell STAT3 โ€ข Immune โ€ฆSee details»

duettx.com - Home - Duet Therapeutics - Duet Tx - Sur.ly

Duettx.com. Creating targeted immunotherapies for treatment-resistant cancers. sur.ly Home - Duet Therapeutics. Creating targeted immunotherapies for treatment-resistant cancers. โ€ฆSee details»

Contact - Duet Therapeutics

Contact Us Corporate Headquarters 251 South Lake Avenue Suite 800 Pasadena, CA 91101 *Required FieldSee details»

Duet Therapeutics Set to Release Scientific Data

Sep 28, 2021 Scopus BioPharmaโ€™s Subsidiary โ€” Duet Therapeutics โ€” Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society Duet โ€ฆSee details»

Company Information - RocketReach

The most common Duet BioTherapeutics email format. is [first] (ex. [email protected]), which is being used by 100.0% of Duet BioTherapeutics work email addresses. Duet BioTherapeutics โ€ฆSee details»

Team - Duet Therapeutics

Duet pairs invention with scientific rigor to develop solutions that restore human health. Duet Therapeutics is a clinical stage immuno-oncology company pioneering the development of โ€ฆSee details»

Duet BioTherapeutics Email Format | Duettx.com Emails - SignalHire

Here are 6 email formats that are most likely used by the Duet BioTherapeutics, where firstNameInitial-lastName (ex. [email protected]) has the highest usage frequency - 55% of the โ€ฆSee details»

Duett, Inc.

Duett is the fastest way for care coordinators to identify providers for care plans, the easiest way for providers to grow their business, and the best way for individuals to choose their care.See details»

Pipeline - Duet Therapeutics

Our Pipeline While Duet is dedicated to moving our drugs into the clinic as quickly as possible, these decisions are driven by scientific results. All our development-stage programs are โ€ฆSee details»

Scientific Approach - Duet Therapeutics - duettx.com

Creating targeted immunotherapies for treatment-resistant cancers.. Home; About; Approach; Pipeline; News & Resources; Contact; MenuSee details»

News & Resources - Duet Therapeutics - duettx.com

Creating targeted immunotherapies for treatment-resistant cancers.. Home; About; Approach; Pipeline; News & Resources; Contact; MenuSee details»

linkstock.net © 2022. All rights reserved